Edificio CIBA
Avda. San Juan Bosco, 13
50009 Zaragoza
Framework for approaching federated causal inference based on real-world observational data sources
M Meurisse, N Schutte, N Van Goethem, F Estupiñán-Romero, E Bernal-Delgado, Framework for approaching federated causal inference based on real-world observational data sources, European Journal of Public Health, Volume 34, Issue Supplement_3, November 2024
Federated causal inference based on real-world observational data sources: application to a SARS-CoV-2 vaccine effectiveness assessment
Marjan Meurisse, Francisco Estupiñán-Romero, Javier González-Galindo, Natalia Martínez-Lizaga, Santiago Royo-Sierra, Simon Saldner, Lorenz Dolanski-Aghamanoukjan, Alexander Degelsegger-Marquez, Stian Soiland-Reyes, Nina Van Goethem & Enrique Bernal-Delgado for the BeYond-COVID project. Federated causal inference based on real-world observational data sources: application to a SARS-CoV-2 vaccine effectiveness assessment. BMC Med Res Methodol
BY-COVID – WP5 – Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment preliminary outputs from Aragon, Spain
Estupiñán-Romero, Francisco, González-Galindo, Javier, Meurisse, Marjan, Martínez-Lizaga, Natalia, Royo-Sierra, Santiago, Van Goethem, Nina, & Bernal-Delgado, Enrique. (2023). BY-COVID – WP5 – Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment preliminary outputs from Aragon, Spain
BY-COVID – WP5 – Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment
Francisco Estupiñán-Romero, Nina Van Goethem, Marjan Meurisse, Javier González-Galindo, Enrique Bernal-Delgado. BY-COVID – WP5 – Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment
BY-COVID – WP5 – Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment – Study protocol
Meurisse, Marjan, Van Goethem, Nina, Estupiñán-Romero, Francisco, González-Galindo, Javier, Royo-Sierra, Santiago, Martínez-Lizaga, Natalia, & Bernal-Delgado, Enrique. (2023). BY-COVID – WP5 – Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment – Study protocol (1.0.3)
BY-COVID Mechanism for data access and use of routine real-world data
Estupiñán-Romero, Francisco, Launa-Garcés, Ramón, Van Dam, Iris, Cosgrove, Shona, Van Goethem, Nina, & Bernal-Delgado, Enrique. (2023). BY-COVID Milestone 2.2 Mechanism for data access and use of routine real-world data
BY-COVID – WP5 – Baseline Use Case: COVID-19 vaccine effectiveness assessment – Data Management Plan
Natalia Martínez-Lizaga, Marjan Meurisse, Francisco Estupiñan-Romero, Nina Van Goethem, & Enrique Bernal-Delgado. (2023). BY-COVID – WP5 – Baseline Use Case: COVID-19 vaccine effectiveness assessment – Data Management Plan
BY-COVID – WP5 – Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment – Common Data Model Specification
Estupiñán-Romero, Francisco, Van Goethem, Nina, Meurisse, Marjan, González-Galindo, Javier, & Bernal-Delgado, Enrique. (2023). BY-COVID – WP5 – Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment – Common Data Model Specification
BY-COVID – WP5 – Baseline Use Case: COVID-19 vaccine effectiveness assessment – Common Data Model Specification
Estupiñán-Romero, Francisco, Van Goethem, Nina, Meurisse, Marjan, González-Galindo, Javier, & Bernal-Delgado, Enrique. (2022). BY-COVID – WP5 – Baseline Use Case: COVID-19 vaccine effectiveness assessment – Common Data Model Specification (1.0.0)